BCHE and Alzheimer disease: Standard pharmacological approach for apathy in AD has relied on optimized use of the Food and Drug Administration-approved drugs for AD, i.e., cholinesterase inhibitors (e.g., donepezil and rivastigmine) and memantine [74].